Highlights
- •Few studies have assessed factors associated with the length of readmission following elective pulmonary lobectomy.
- •In this study including 19947 receiving lobectomies, readmissions were common, occurring in 10.9% of cases.
- •Shorter readmission length of stay was associated with patient insurance status and being readmitted to a non-index facility.
- •Primary diagnosis codes at readmission also differed significantly with length of readmission.
- •Interventions that reduce readmissions are critical to mitigate costs and improve patient outcomes following lobectomy.
Abstract
Background
Reducing readmissions is critical for improving patient care and lowering costs. Despite
this, few studies have assessed length of readmission following pulmonary lobectomy.
Methods
Using the Healthcare Cost and Utilization Project New York State Inpatient Database,
we identified adult patients undergoing elective pulmonary lobectomy (2007–2015) and
assessed readmission within 30 days of hospital discharge. We analyzed the relationship
between length of readmission and post-operative morbidity and mortality as well as
primary diagnoses at readmission.
Results
Of 19947 included patients, 2173 (10.9%) were readmitted within 30 days. The median
(IQR) length of readmission was 5 (2–8) days. Longer length of readmission was associated
with significantly higher likelihood of major complication (for every 1-day increase,
aOR = 1.14, 95% CI = 1.12–1.17, p < 0.001) and mortality (aOR = 1.03, 95% CI = 1.02–1.04,
p < 0.001) within 90 days. Primary diagnosis codes at readmission differed significantly
with length of readmission.
Conclusions
Interventions that target short readmissions may help to prevent a proportion of readmissions
following elective lung resection.
Keywords
Abbreviations:
AHRQ (Agency for Healthcare Research and Quality), HCUP (Healthcare Cost and Utilization Project), SID (State Inpatient Database), CMS (Centers for Medicare and Medicaid Services), ICD (International Classification of Diseases)To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The American Journal of SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Hospital-readmission risk — isolating hospital effects from patient effects.N Engl J Med. 2017; 377: 1055-1064https://doi.org/10.1056/NEJMsa1702321
- Hospital readmissions reduction program (HRRP) | CMS.
- The society of thoracic surgeons composite score rating for pulmonary resection for lung cancer.in: Annals of Thoracic Surgery. 109. Elsevier USA, 2020: 848-855https://doi.org/10.1016/j.athoracsur.2019.08.114
- Incidence and factors associated with hospital readmission after pulmonary lobectomy.in: Annals of Thoracic Surgery. 101. Elsevier USA, 2016: 434-443https://doi.org/10.1016/j.athoracsur.2015.10.001
- Unexpected readmission after lung cancer surgery: a benign event? Read at the 95th annual meeting of the American association for thoracic surgery.(April 25-29, 2015)in: Journal of Thoracic and Cardiovascular Surgery. 150. Mosby Inc., Seattle, Washington2015: 1496-1505https://doi.org/10.1016/j.jtcvs.2015.08.067 (e5)
- Readmission after lung cancer resection is associated with a 6-fold increase in 90-day postoperative mortality.J Thorac Cardiovasc Surg. 2014; 148 (e1): 2261-2267https://doi.org/10.1016/j.jtcvs.2014.04.026
- A comparison of length of stay, readmission rate, and facility reimbursement after lobectomy of the lung.in: Annals of Thoracic Surgery. 96. Elsevier, 2013: 1740-1746https://doi.org/10.1016/j.athoracsur.2013.06.053
- Socioeconomic factors are associated with readmission after lobectomy for early stage lung cancer.in: Annals of Thoracic Surgery. 102. Elsevier USA, 2016: 1660-1667https://doi.org/10.1016/j.athoracsur.2016.05.060
- Health care utilization among surgically treated Medicare beneficiaries with lung cancer.Ann Thorac Surg. 2009; 88: 1749-1756https://doi.org/10.1016/j.athoracsur.2009.08.006
- Readmission after Lobectomy for Lung Cancer: Not All Complications Contribute Equally.Ann Surg, 2019https://doi.org/10.1097/SLA.0000000000003561 (Published online)
- https://www.hcup-us.ahrq.gov/db/state/siddist/SID_Introduction.jspDate: September 15, 2021
- Utilization trends, outcomes, and cost in minimally invasive lobectomy.in: Annals of Thoracic Surgery. 108. Elsevier USA, 2019: 1648-1655https://doi.org/10.1016/j.athoracsur.2019.06.049
- Comorbidity measures for use with administrative data.Med Care. 1998; 36: 8-27https://doi.org/10.1097/00005650-199801000-00004
- Care fragmentation is associated with increased short-term mortality during postoperative readmissions: a systematic review and meta-analysis.Surgery. 2019; 165: 501-509https://doi.org/10.1016/J.SURG.2018.08.021
- Comparison of rates and outcomes of readmission to index vs nonindex hospitals after major cancer surgery.JAMA Surg. 2018; 153: 719-727https://doi.org/10.1001/JAMASURG.2018.0380
- Fragmentation of care after surgical discharge: non-index readmission after major cancer surgery.J Am Coll Surg. 2016; 222 (e2): 780-789https://doi.org/10.1016/J.JAMCOLLSURG.2016.01.052
- Fragmented care in the treatment of rectal cancer and time to definitive therapy.J Am Coll Surg. 2021; 232: 27-33https://doi.org/10.1016/j.jamcollsurg.2020.10.017
- Guide to Enhanced Recovery for Cancer Patients Undergoing Surgery.Ann Surg Oncol, 2021https://doi.org/10.1245/s10434-021-09882-3 (Published online)
- Analysis of delayed surgical treatment and oncologic outcomes in clinical stage I non–small cell lung cancer.JAMA Netw Open. 2021; 4 (e2111613-e2111613)https://doi.org/10.1001/jamanetworkopen.2021.11613
- Effects of delayed surgical resection on short-term and long-term outcomes in clinical stage i non-small cell lung cancer.Ann Thorac Surg. 2015; 99: 1906-1913https://doi.org/10.1016/j.athoracsur.2015.02.022
- Volume pledge is not associated with better short-term outcomes after lung cancer resection.J Clin Oncol. 2020; 38: 3518-3527https://doi.org/10.1200/JCO.20.00329
- Keeping a safe distance from surgical volume standards.J Clin Oncol. January 24, 2022; (Published online) (JCO.21)02875https://doi.org/10.1200/JCO.21.02875
- Dissemination and implementation science in cardiothoracic surgery: a review and case study.Ann Thorac Surg. 2021; (0) (0)https://doi.org/10.1016/J.ATHORACSUR.2021.08.007
- Assessment of Preoperative Opioid Use Prevalence and Clinical Outcomes in Pulmonary Resection.Ann Thorac Surg, 2020https://doi.org/10.1016/j.athoracsur.2020.07.043 (Published online)
- Routine Collection of Patient Reported Outcomes in Thoracic Surgery: A Quality Improvement Study.Ann Thorac Surg, July 2, 2021https://doi.org/10.1016/J.ATHORACSUR.2021.05.091 (Published online)
- Practical guide to surgical data sets: national surgical quality improvement program (NSQIP) and pediatric NSQIP.JAMA Surg. 2018; 153: 764-765https://doi.org/10.1001/jamasurg.2018.0486
- Assessing readmission after general, vascular, and thoracic surgery using.ACS-NSQIP. Ann Surg. 2013; 258: 430-437https://doi.org/10.1097/SLA.0B013E3182A18FCC
Article info
Publication history
Published online: August 03, 2022
Accepted:
July 31,
2022
Received in revised form:
May 31,
2022
Received:
March 23,
2022
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
